Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Plos One
|
July 28, 2010
Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells
Han-Ching Tseng, Aida Arasteh, Avina Paranjpe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2005
Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease
James C Dodge, Jennifer Clarke, Antonius Song, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 3, 2006
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis
Marco A Passini, James C Dodge, Jie Bu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2008
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity
James C Dodge, Amanda M Haidet, Wendy Yang, et al.
Science Translational Medicine
|
December 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
Xue Han, Matthew D Vesely, Wendy Yang, et al.
Blood
|
June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
Akihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 21, 2021
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
The Journal of Infectious Diseases
|
December 10, 2021
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Plos One
|
July 28, 2010
Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells
Han-Ching Tseng, Aida Arasteh, Avina Paranjpe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 23, 2005
Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease
James C Dodge, Jennifer Clarke, Antonius Song, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 3, 2006
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis
Marco A Passini, James C Dodge, Jie Bu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2008
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity
James C Dodge, Amanda M Haidet, Wendy Yang, et al.
Science Translational Medicine
|
December 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
Xue Han, Matthew D Vesely, Wendy Yang, et al.
Blood
|
June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
Akihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 21, 2021
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
The Journal of Infectious Diseases
|
December 10, 2021
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
Page
of 7